The full name of your medicine is Glypressin solution for injection. Glypressin is a ready-to-use solution for injection containing . Ferring Pharmaceuticals Ltd. Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept GLYPRESSIN ®. On 11th May , the MHRA granted Ferring Pharmaceuticals Limited a Marketing. Authorisation (licence) for Glypressin mg/ml Solution for Injection (PL.

Author: Mezir Muzilkree
Country: Mongolia
Language: English (Spanish)
Genre: Technology
Published (Last): 8 February 2004
Pages: 450
PDF File Size: 17.46 Mb
ePub File Size: 6.63 Mb
ISBN: 315-3-40643-365-9
Downloads: 33717
Price: Free* [*Free Regsitration Required]
Uploader: Moshakar

Transient nausea Transient vomiting. To view the changes to a medicine you must sign up and log in. Posology In acute variceal bleeding: There is no data available regarding dosage recommendation in these special patient categories. Intestinal ischaemia Peripheral cyanosis Hot flushes.

glyprsssin Concomitant treatment with medicinal products with a known bradycardic effect e. Company contact details Glypfessin Pharmaceuticals Ltd. Pregnancy, puerperium and perinatal conditions. Transient abdominal cramps Transient diarrhoea. Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Ferring Group.


One ampoule contains 1mg terlipressin acetate in 8. Keep the ampoules in the outer carton in order to protect from light.

Caution should be exercised in treating patients with hypertension or recognised heart disease. Last updated on eMC: Glypressin is indicated in the treatment of bleeding oesophageal varices.

Glypressin mg/ml Solution for Injection – Summary of Product Characteristics (SmPC) – (eMC)

Glypressin may have harmful effects on pregnancy and foetus. Respiratory distress Respiratory failure. Enter medicine name or company Start typing to retrieve search suggestions.

Metabolism and nutrition disorders. This information is intended for use by health professionals.

Gastroenterology – Ferring Corporate

Lysine vasopressin reaches maximum plasma levels about 1 – 2 hours following intravenous administration and has a duration of activity of 4 – 6 hours.

Reporting suspected adverse reactions after authorisation of the medicinal product is important. Find out more here. Method of administration Intravenous injection use. Following intravenous injection, three glycyl moieties are enzymatically cleaved from the N-terminus to release lysine vasopressin. Topical formulations suppositories and hlypressin are also available for administration via the rectum, allowing a high concentration of the drug to be in contact with areas of inflammation at the lower end of the digestive tract.


Peripheral vasoconstriction Peripheral ischaemia Facial pallor Hypertension. Hypersensitivity to terlipressin acetate or any of the excipients listed in section 6. To bookmark a medicine you must sign up and log feerring.

There is no relevant use of Glypressin in glypresain population.

Marketing authorisation holder 8. Continue typing to refine. Sign Up Log In Cancel. For advice on medical issues please consult your local medical practitioner.

Glypressin 0.12mg/ml Solution for Injection

Any unused product or waste material should be disposed of in accordance with local requirements. Atrial fibrillation Ventrical extrasystoles Tachycardia Chest pain Myocardial infarction Fluid overload with pulmonary oedema Torsade de pointes Cardiac failure. Spontaneous abortion and malformation have been shown in rabbits after treatment with Glypressin.

The hypotensive effect of non-selective beta-blockers on the portal vein is increased with terlipressin. This site uses cookies. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme, website: